Centre Leon Berard: Sarcoma trials
The registry lists 16 Sarcoma studies with Centre Leon Berard as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 1 4Phase 2 4Phase 3 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Improved Management of Soft Tissue Sarcomas Patients With an Optimized and Innovative Sorting Technology for Circulating Tumor CellsNot yet recruitingNCT07401355Not applicable
- Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After RadiotherapyRecruitingNCT05944913Not applicable
- Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STSRecruitingNCT05739084
- Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue SarcomaRecruitingNCT05684874Not applicable
- Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare SubtypeRecruitingNCT04741438Phase 3
- Multicentre Retrospective Cohort Study of Palliative Care Pathways in Patients Who Died From SarcomaCompletedNCT07532668
- Economic Evaluation of Sarcoma Patients Management in FranceStatus unknownNCT05272358
- HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue SarcomasActive, not recruitingNCT05180695Phase 1/2
- A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.Active, not recruitingNCT04671693Not applicable
- Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.CompletedNCT04367779
- MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue SarcomaCompletedNCT04216953Phase 1/2
- Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With RadiotherapyActive, not recruitingNCT03474094Phase 2
- RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.Active, not recruitingNCT03375437Not applicable
- First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10TerminatedNCT01469975Phase 1
- Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant RadiotherapyCompletedNCT01308034Phase 1
- Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment FailureCompletedNCT01136499Phase 2